Knightsbridge Asset Management »

Regeneron Pharmaceuticals shares owned by Knightsbridge Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Knightsbridge Asset Management from 13F filings

Historical chart of Knightsbridge Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Knightsbridge Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Knightsbridge Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $208k 369 562.29

More positions owned by Knightsbridge Asset Management

Wisdomtree Tr Floatng Rat Trea (USFR)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Spdr Series Trust Portfolio S&p500 (SPLG)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Microsoft Corporation (MSFT)
Hldgs (UAL)
Kraneshares Trust California Carb (KCCA)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Alphabet Cap Stk Cl A (GOOGL)
Western Digital (WDC)
Ishares Tr Core Div Grwth (DGRO)
Amazon (AMZN)
Centene Corporation (CNC)

View all positions for Knightsbridge Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals